1.
Clin Infect Dis
; 78(6): 1425-1428, 2024 Jun 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38289725
RESUMO
We report a fatal case of New Delhi metallo-ß-lactamase (NDM)-producing Escherichia coli in a bacteremic patient with sequential failure of aztreonam plus ceftazidime-avibactam followed by cefiderocol. Acquired resistance was documented phenotypically and mediated through preexisting and acquired mutations. This case highlights the need to rethink optimal treatment for NDM-producing organisms.